DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Roswell Park Cancer Institute
Roswell Park Cancer Institute
NextCure, Inc.
Dana-Farber Cancer Institute
Amgen
Merck Sharp & Dohme LLC
Takeda
Pfizer
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
Boehringer Ingelheim
Boehringer Ingelheim
Massachusetts General Hospital